Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1930 Jan 1;51(1):99–122. doi: 10.1084/jem.51.1.99

THE TRANSFORMATION OF PNEUMOCOCCAL TYPES

I. THE CONVERSION OF R FORMS OF PNEUMOCOCCUS INTO S FORMS OF THE HOMOLOGOUS TYPE

Martin H Dawson 1
PMCID: PMC2131798  PMID: 19869681

Abstract

R forms of Pneumococcus may be converted into S forms of the homologous Type. In addition to the methods previously reported,—(1) animal passage and (2) growth in anti-R sera,—conversion may be effected by the following procedures as employed by Griffith; (1) The subcutaneous injection, in white mice, of large amounts of living R organisms. (2) The subcutaneous injection, in white mice, of small amounts of living R organisms together with the heat-killed bacteria from large amounts of homologous S cultures. There are "varying degrees of constancy of the R variant"; but by these means it has been possible to effect conversion of all R forms selected. Attempts to cause a further "degradation" of R organisms by continued growth in homologous immune serum have been unsuccessful. Type II S and III S vaccines are equally effective in producing conversion when heated for 15' at 60°C., or for 15' at 100°C. Type I S vaccine, however, while effective in causing conversion when heated for 15' at 60°C., apparently loses this property when heated for 15' at 100°C. R vaccines, and vaccines of other organisms, when injected together with live R cultures, have always failed to produce conversion. The causes responsible for conversion under these experimental conditions are discussed and the possibility of the occurrence of a similar process under natural conditions in human beings is indicated.

Full Text

The Full Text of this article is available as a PDF (1,019.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avery O. T., Heidelberger M. IMMUNOLOGICAL RELATIONSHIPS OF CELL CONSTITUENTS OF PNEUMOCOCCUS : SECOND PAPER. J Exp Med. 1925 Aug 31;42(3):367–376. doi: 10.1084/jem.42.3.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Avery R. C., Leland S. J. A SIMPLE METHOD FOR THE ISOLATION OF PURE CULTURES FROM SINGLE BACTERIAL CELLS. J Exp Med. 1927 May 31;45(6):1003–1007. doi: 10.1084/jem.45.6.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dawson M. H. THE INTERCONVERTIBILITY OF "R" AND "S" FORMS OF PNEUMOCOCCUS. J Exp Med. 1928 Mar 31;47(4):577–591. doi: 10.1084/jem.47.4.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dochez A. R., Avery O. T. THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH. J Exp Med. 1917 Oct 1;26(4):477–493. doi: 10.1084/jem.26.4.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Heidelberger M., Avery O. T. THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : SECOND PAPER. J Exp Med. 1924 Aug 31;40(3):301–317. doi: 10.1084/jem.40.3.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Reimann H. A. VARIATIONS IN SPECIFICITY AND VIRULENCE OF PNEUMOCOCCI DURING GROWTH IN VITRO. J Exp Med. 1925 Apr 30;41(5):587–600. doi: 10.1084/jem.41.5.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Sia R. H. STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : VI. THE SPECIFIC EFFECT OF PNEUMOCOCCUS SOLUBLE SUBSTANCE ON THE GROWTH OF PNEUMOCOCCI IN NORMAL SERUM-LEUCOCYTE MIXTURES. J Exp Med. 1926 Apr 30;43(5):633–645. doi: 10.1084/jem.43.5.633. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES